INS and type 2 diabetes mellitus: In a further analysis, we analysed the mean change in HbA1c from baseline to 6, 12 and 24 months after the isCGM index date for adults with type 2 diabetes and suboptimal glucose management, treated with MDI (T2D-MDI) or with basal insulin only (T2D-B), compared with prior use of BGM only (ESM Table 3).